David Buck
Stock Analyst at B. Riley Securities
(0.20)
# 3,907
Out of 4,671 analysts
14
Total ratings
20%
Success rate
-34.64%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Buck
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MNOV MediciNova | Assumes: Buy | $22 | $2.08 | +957.69% | 2 | Mar 25, 2019 | |
SUPN Supernus Pharmaceuticals | Maintains: Buy | $68 → $65 | $36.14 | +79.86% | 3 | Nov 12, 2018 | |
JAZZ Jazz Pharmaceuticals | Maintains: Buy | $219 → $190 | $122.79 | +54.74% | 4 | Nov 8, 2018 | |
AMRX Amneal Pharmaceuticals | Maintains: Buy | $26 → $28 | $8.25 | +239.39% | 2 | Aug 22, 2018 | |
ALKS Alkermes | Initiates: Buy | $60 | $29.25 | +105.13% | 1 | Jun 6, 2018 | |
EVOK Evoke Pharma | Reinstates: Buy | $1,440 | $4.39 | +32,701.82% | 2 | Oct 19, 2017 |
MediciNova
Mar 25, 2019
Assumes: Buy
Price Target: $22
Current: $2.08
Upside: +957.69%
Supernus Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $68 → $65
Current: $36.14
Upside: +79.86%
Jazz Pharmaceuticals
Nov 8, 2018
Maintains: Buy
Price Target: $219 → $190
Current: $122.79
Upside: +54.74%
Amneal Pharmaceuticals
Aug 22, 2018
Maintains: Buy
Price Target: $26 → $28
Current: $8.25
Upside: +239.39%
Alkermes
Jun 6, 2018
Initiates: Buy
Price Target: $60
Current: $29.25
Upside: +105.13%
Evoke Pharma
Oct 19, 2017
Reinstates: Buy
Price Target: $1,440
Current: $4.39
Upside: +32,701.82%